N
Norihiro Kokudo
Researcher at University of Tokyo
Publications - 918
Citations - 39158
Norihiro Kokudo is an academic researcher from University of Tokyo. The author has contributed to research in topics: Liver transplantation & Hepatectomy. The author has an hindex of 86, co-authored 849 publications receiving 32035 citations. Previous affiliations of Norihiro Kokudo include Juntendo University & Meikai University.
Papers
More filters
Journal ArticleDOI
Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation.
Yoji Kishi,Yasuhiko Sugawara,Nobuhisa Akamatsu,Junichi Kaneko,Sumihito Tamura,Norihiro Kokudo,Masatoshi Makuuchi +6 more
TL;DR: The results of the preliminary study warrant a randomized control trial to examine the feasibility of splenectomy and preemptive viral therapy during liver transplantation for hepatitis C.
Journal ArticleDOI
Intraoperative direct measurement of hepatic arterial buffer response in patients with or without cirrhosis
Taku Aoki,Hiroshi Imamura,Junichi Kaneko,Yoshihiro Sakamoto,Yutaka Matsuyama,Norihiro Kokudo,Yasuhiko Sugawara,Masatoshi Makuuchi +7 more
TL;DR: The baseline HABR appears to be continuously activated in patients with LC; this phenomenon probably results in the impairment of the acute HABr.
Journal ArticleDOI
R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.
Luca Viganò,Guido Costa,Matteo Cimino,Fabio Procopio,Matteo Donadon,Daniele Del Fabbro,Jacques Belghiti,Norihiro Kokudo,Masatoshi Makuuchi,Jean Nicolas Vauthey,Guido Torzilli +10 more
TL;DR: A negative margin is still standard for CLM, but R1 resection is no longer just a technical error and should be part of the modern multidisciplinary, aggressive approach to CLM.
Journal ArticleDOI
Sphingosine kinase-1, S1P transporter spinster homolog 2 and S1P2 mRNA expressions are increased in liver with advanced fibrosis in human.
Masaya Sato,Hitoshi Ikeda,Baasanjav Uranbileg,Makoto Kurano,Daisuke Saigusa,Junken Aoki,Harufumi Maki,Hiroki Kudo,Kiyoshi Hasegawa,Norihiro Kokudo,Yutaka Yatomi +10 more
TL;DR: S1P may be actively generated, transported to outside the cells, and bind to its specific receptor in human liver to play a role in fibrosis or inflammation, and altered S1P metabolism in fibrotic liver may be their therapeutic target.
Journal ArticleDOI
Living donor liver transplantation for biliary atresia: An analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society
Mureo Kasahara,Koji Umeshita,Seisuke Sakamoto,Akinari Fukuda,Hiroyuki Furukawa,Shotaro Sakisaka,Eiji Kobayashi,Eiji Tanaka,Yukihiro Inomata,Seiji Kawasaki,Mitsuo Shimada,Norihiro Kokudo,Hiroto Egawa,Hideki Ohdan,Shinji Uemoto +14 more
TL;DR: It is concluded that LDLT for BA is a safe and effective treatment modality that does not compromise living donors and the optimum timing for LT is crucial for a successful outcome, and early referral to transplantation center can improve the short‐term outcomes of LT for BA.